Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998
The SANAD II Study of the Effectiveness and Cost-Effectiveness of Valproate Versus Levetiracetam for Newly Diagnosed Generalised and Unclassifiable Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial
Lancet 397:1375-1386, Marson, A.,et al, 2021
Drug Treatment of Epilepsy in Adults
BMJ 348:g2546, Schmidt, D. & Schachter, S.C., 2014
Child Development Following In Utero Exposure: Levetiracetam vs Sodium Valproate
Neurol 76:383-389, Shallcross,R.,et al, 2011
Initial Management of Epilepsy
NEJM 359:166-176, French,J.A. &Pedley,T.A., 2008
The SANAD Study of Effectiveness of Valproate,Lamotrigine,or Topiramate for Generalised and Unclassifiable Epilepsy:An Unblinded Randomised Controlled Trial
Lancet 369:1016-1026, Marson,A.G.,et al, 2007
Seizure Control and Treatment in Pregnancy, Observations from the EURAP Epilepsy Pregnancy Registry
Neurol 66:354-360, The EURAP Study Group, 2006
Managing Women With Epilepsy
BMJ 320:3-4, Wiebe,S., 2000
Population Based, Prospective Study of the Care of Women with Epilepsy in Pregnancy
BMJ 321:674-675, Fairgrieve,S.D. et al, 2000
Analysis of Prenatal and Gestational Care Given to Women with Epilepsy
Neurol 51:1039-1045, Seale,C.G.,et al, 1998
Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998
Seizure Disorder
Ciba Clin Symposia 46:4-34, Devinsky,O., 1994